InventionMed S.A. (WSE:INM)

Market Cap	32.14M
Revenue (ttm)	2.01M
Net Income (ttm)	-3.73M
Shares Out	202.79M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	86,222
Average Volume	273,343
Open	0.1610
Previous Close	0.1585
Day's Range	0.1575 - 0.1610
52-Week Range	0.1500 - 0.2350
Beta	0.20
RSI	47.32
Earnings Date	Nov 14, 2025

About InventionMed

InventionMed S.A. focuses on the development of medical simulators based on Virtual Realty technology for use in education in esthetic and clinical dermatology. Its flagship project is TutorDerm, a simulator and an application that lets users perform actions necessary to treat specific dermatological diseases. The company also offers double immersion, and Virtual Syringe, a training equipment for specialists in clinical and aesthetic dermatology. InventionMed S.A. was incorporated in 2012 and is based in Bydgoszcz, Poland.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 5
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: INM

Financial Performance

In 2024, InventionMed's revenue was 277,760, an increase of 45810.74% compared to the previous year's 605. Losses were -4.41 million, 133.2% more than in 2023.